Investors

Event Details

Dec 7, 2022 3:30 PM EST

Virtual

Bruce Jacobs, CFA, MBA
Chief Financial Officer
investors@kymeratx.com

Christopher F. Brinzey
Westwicke, an ICR Company for Kymera Therapeutics
chris.brinzey@westwicke.com
+ 1 339.970.2843

Todd Cooper
Sr. Vice President, Corporate Affairs
media@kymeratx.com